Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

James B. Powell

Laboratory Corporation of America Holdings

Genomics Core Leuven provides services in long-read sequencing and bioinformatics analysis, focusing on technologies for data management and analysis in the fields of healthcare and biomedical research.

Genomics Core Leuven

AHRM is a specialty CRO that focuses on Health Economics and Outcomes Research. The company integrates and conducts clinical trials and outcomes research across various therapeutic areas.

Applied Healthcare Research Management Inc. (AHRM)

DigiM Solution provides drug product development and microstructure contract research organization (CRO) services, along with software solutions.

Metric
Company Name	Laboratory Corporation of America Holdings	Genomics Core Leuven	Applied Healthcare Research Management Inc. (AHRM)	DigiM Solution
Symbol	LH
MSH ID	COM:LABCORP	BE:GENOMICSCORE	COM:AHRMINC	COM:DIGIMSOLUTION
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Diagnostics & Research	Biotechnology	Contract Research Organization (CRO)	Pharmaceuticals
Country	US	BE	US	US
Stage
Employee Count	67K
Website	labcorp.com	genomicscore.be	ahrminc.com	digimsolution.com
LinkedIn			applied-healthcare-resource-management	digim-solution
Founders

Metric
Market Cap	16.89B
Enterprise Value
Monthly Web Traffic		1	134
Web Traffic Growth			1.58
Valuation
Raised Capital

Metric
Revenue	12.16B
Revenue (LTM)
Revenue (NTM)
Gross Profit	3.15B
EBITDA	1.70B
Operating Income	1.12B
Net Income	418M
EPS	4.80
Diluted EPS	4.77
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.27
Operating Profit Margin	0.09
EBITDA Margin	0.14
Net Profit Margin	0.04
Return on Equity	0.06
Return on Assets	0.03
Return on Capital Employed	0.09

COM:LABCORP

Labcorp

Last Close

240.17

22/11 21:00

Market Cap

16.89B

Beta: -

Volume Today

436.36K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	28.87
P/B Ratio	2.42
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.59
EV Multiple	8.77

Metric
Days Sales Outstanding	55.66
Days Payables Outstanding	25.45
Days Inventory Outstanding	19.25
Operating Cycle	84.65
Cash Conversion Cycle	52.97
Asset Turnover	0.77

Metric
Operating Cash Flow	1.33B
Free Cash Flow	874.10M
Cash Flow to Debt	0.26
Operating Cash Flow/Sales	0.11
Free Cash Flow Yield	0.05

Metric
Cash & Equivalents	536.80M
Accounts Receivable	-75.30M
Inventory	474.60M
Goodwill	6.14B
Debt to Capitalization	0.43
Debt to Assets	0.37
Current Ratio	1.36
Quick Ratio	0.82

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue
SG&A to Revenue